Literature DB >> 6709700

The instrumental use of rating scales for depression.

P Bech.   

Abstract

This statistical analysis of the instrumental use of rating scales for depression has considered the following issues: Comprehensiveness, item definition, item combination, administration, applicability, homogeneity, inter-observer reliability, and validity. Within the compartment or dimension of severity of depression a subscale of the Hamilton Depression Scale (or the Melancholia Scale) was shown to have reached an instrumental perfection, e.g. as an outcome measure of antidepressant treatment. Within the compartment of personality scales the Marke Nyman Temperament Scale demonstrated that unipolar depressed patients with a score pattern similar to bipolar patients responded well and favourably to lithium. Within the compartment of diagnostic rating scales for depression the Newcastle Scales showed that for patients with an endogenous score, but not for patients with a non-endogenous score, a significant correlation existed between plasma levels of imipramine or clomipramine and clinical response.

Entities:  

Mesh:

Year:  1984        PMID: 6709700     DOI: 10.1055/s-2007-1017402

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  3 in total

1.  [Dimensions of the Hamilton Depression Scale. Factor analysis studies].

Authors:  W Maier; M Philipp; A Gerken
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

2.  From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings.

Authors:  Konstantinos N Fountoulakis; Roger S McIntyre; André F Carvalho
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

3.  No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.

Authors:  Konstantinos N Fountoulakis; Areti Angeliki Veroniki; Melina Siamouli; Hans-Jürgen Möller
Journal:  Ann Gen Psychiatry       Date:  2013-08-13       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.